Bell Investment Advisors, Inc Karuna Therapeutics, Inc. Transaction History

Bell Investment Advisors, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$161.01 - $317.85 $161 - $317	-1 Reduced 16.67%	5 $1,000
Q3 2023 Nov 08, 2023	BUY	$164.66 - $218.08 $493 - $654	3 Added 100.0%	6 $1,000
Q2 2023 Aug 09, 2023	SELL	$176.32 - $240.22 $528 - $720	-3 Reduced 50.0%	3 $0
Q1 2023 May 10, 2023	BUY	$161.33 - $204.36 $483 - $613	3 Added 100.0%	6 $1,000
Q4 2022 Feb 08, 2023	SELL	$191.53 - $236.82 $957 - $1,184	-5 Reduced 62.5%	3 $0
Q3 2022 Nov 09, 2022	SELL	$123.79 - $277.42 $7,179 - $16,090	-58 Reduced 87.88%	8 $2,000
Q2 2022 Aug 12, 2022	BUY	$93.97 - $143.33 $6,202 - $9,459	66 New	66 $8,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Bell Investment Advisors, Inc with notifications on news.